NovelStem International IR ($NSTM)

NovelStem Owns ~30% financial interest in a stem cell-based diagnostic platform to identify resistance to cancer treatments, prior to treatment.

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial Update in Amended Form 10. #CancerTreatment #ChemotherapyResistance #Diagnostics #Form10 #Microcaps #Biotechnology #OTC #Biotech https://t.co/CsqnjY5wip

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM: NovelStem Announces Material Developments and Strategic Repositioning of the Company. #OTC #Stocks https://t.co/jqrAP6448p

[stock setter @MarcJacksonLA]

-
$OCGN
- HC Wainwright reiterates Ocugen
$7 price target, Buy rating

- Chardan Capital maintains $5 target, Buy rating
-
$OMIC
- Goldman Sachs lowers Singular Genomic Systems to $0.75 from $0.85, Neutral rating
-

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM: Filed its 10-Q for the first quarter ended March 31, 2024 today – which along with its 2023 Annual Report on form 10-K can be accessed here: https://t.co/XNMiRkKto5 #SECReporting #10K #Audit #Auditor #FinancialResults #Biotech #Microcaps #OTC

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM: On Jan. 22, NovelStem's Board approved Kreit & Chiu CPA LLP as its new independent public accounting firm for its fiscal year ending Dec. 31, 2023. #SECReporting #10K #Audit #Auditor #FinancialResults #biotech #Microcap #OTC https://t.co/7GY6YyNRs1

[stock setter @MarcJacksonLA]

$NSTM NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-K | BioSpace https://t.co/lFPdQ8o817 #jobs

[TMX Newsfile @newsfile_corp]

Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandising

Full Story: https://t.co/oooLD27QM5

@NSTM_IR $NSTM #Books #CancerTreatment #Cybercrime #JointVenture #OTC

[NovelStem International IR ($NSTM) @NSTM_IR]

Proceeds to be used to fund/market stem-cell biotech platform development.

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM Arbitration Confirms NovelStem JV's Rights to Exploit 'Tom Clancy's Net Force' Franchise via Film, TV, Online, Streaming, Gaming. #books #cybercrime #entertainment #microcap #animation #arbitration #gaming #streaming #espionage #enovella #novella https://t.co/C8R6w8gbcH

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM: Arbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and Merchandising; proceeds will fund stem-cell platform development. #b... https://t.co/vcwLZbdsK0

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM: Our Form 10-Q for the first quarter ended March 31, 2023, as well as our 10-K for 2022 are located here: https://t.co/XNMiRkL1dD

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM: On 1-13, the Board of Novelstem appointed Jan Loeb as President & Christine Jenkins, Vice President of the Company. Loeb has served as Chairman since 2018 & Executive Chairman since September 2022. Jenkins has served as C... https://t.co/jhkCSFmlQr

[360Dx @360DxNews]

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform. The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance. https://t.co/tYMnYZAbFZ

[MedPub.io @MedPubApp]

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform

#MedPub #MedTwitter #MedEd #MedNews
https://t.co/0nR91qxVbl

[GenomeWeb @GenomeWeb]

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform. The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance. https://t.co/0hVungQS3D

[BiotechTechNow @MedTechNow_]

more #TeamWork

@NSTM_IR's affiliate #NewStem announces new collab with @MSK_Strategy

@AGCBiologics, @WLGore collab on new #Protein A-based #purification #tech for #AntibodyTherapies

@anumanainc, @pfizer partner to enable early detection of underdiagnosed #CardiovascularDisease

[NovelStem International IR ($NSTM) @NSTM_IR]

https://t.co/fjpTPTdqvI $NSTM

[David C Collins @CollinsIR]

NewStem Collaboration with @MSKCancerCenter Innovation Hub on Oncology-Diagnostic $NSTM @NSTM_IR https://t.co/elm7k7xky1

[Amber Deese Owens @AmberOwens18]

Memorial Sloan's innovation hub to help commercialize new oncology platform https://t.co/5JxSx9OUUm

[NovelStem International IR ($NSTM) @NSTM_IR]

$NSTM: Memorial Sloan's Innovation Hub to help commercialize new oncology platform. #CancerTreatment #ChemotherapyResistance #Diagnostics #Genetics #Microcaps https://t.co/cNuI9Ft4Br

[Precision Oncology News @PrecOncNews]

NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform. The Israeli startup called this collaboration a necessary step toward commercializing its CE-marked NewStem Software Diagnostic Device for reducing oncology drug resistance. https://t.co/OoztDVj7xm